WO2011054322A1 - Antifungal mixture with fungal organism pythium oligandrum - Google Patents
Antifungal mixture with fungal organism pythium oligandrum Download PDFInfo
- Publication number
- WO2011054322A1 WO2011054322A1 PCT/CZ2009/000154 CZ2009000154W WO2011054322A1 WO 2011054322 A1 WO2011054322 A1 WO 2011054322A1 CZ 2009000154 W CZ2009000154 W CZ 2009000154W WO 2011054322 A1 WO2011054322 A1 WO 2011054322A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pythium oligandrum
- fungal
- mixture
- fungal organism
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Definitions
- the invention relates to an antifungal mixture with fungal organism Pythium oligandrum designed for fighting fungi including fungal diseases and bacteria.
- Fungi and fungal diseases are a problem of every society and especially fungal diseases of skin of both people and animals belong to frequently occurring diseases of people and animals. Such fungal diseases are even more serious because they are usually transmitted not only by a direct contact of the sick and the healthy but also through the objects, which were in contact with the source of infection.
- Such methods also include e.g. the application of the fungus Pythium oligandrum according to the document CZ 9883 U1 in the form of the biological preparation for fighting the origins of dermatophysis, which includes the said fungal organism in the form of oospora as the effective substance, when the total number of oospora is 2 x I0 5 in 1 g of the preparation as a maximum.
- this solution has a limited range of application and its effective substance is only bound on the inorganic carrier, which is silicon dioxide.
- Fungi from walls and fungi, yeast fungi and bacteria from various objects are removed by means of a series of different preparations, which are, however, never based on the application of the effective substance of the fungal organism Pythium oligandrum.
- the fungal organism Pythium oligandrum from the kingdom Chromista - Stramenopila is a strong mycoparasite; it parasites over 20 families of causative agents of fungal diseases and represents the dividing line between fungi and protozoa because of its sexual as well as asexual reproduction.
- the fibres of Pythium oligandrum penetrate the cells of the parasite (fungi, yeast fungi, bacteria) and draw the substances required for its own nutrition from them. On the basis of nutrition and spatial competition, it squeezes out the pathogens from the spaces.
- the nature of the activity of this fungus is, therefore, parasiting on fungi with the simultaneous production of enzymes, which further increase the efficiency of the fungus.
- Pythium oligandrum attacks the opponent with direct parasitism.
- Pythium oligandrum disappears from that locality (both human and animal bodies do not represent a natural environment for it and it cannot adapt to such environment) and it gives way for the re-settlement of the so-called normal micro-flora or, unless it finds new nutrition (fungi), it is encapsulated into dormancy conditions and its life cycle is paused.
- Pythium oligandrum can be used independently or in combination with other carriers (components) than silicon dioxide, which is also used according to the aforesaid applied design.
- the number of the reproduction organs of the fungal organism Pythium oligandrum according to this technical solution is higher than 2 x 10 5 in 1 g of the mixture.
- the weight expression it means that the mixture consists of 0.001 to 25 weight portions of Pythia oligandrum as a minimum and 75 to 99.999 weights portions of inert components.
- Pythium oligandrum also suppresses symptoms of other diseases than dermatophysis, namely also microbiological settlement of proboscis, other inflammations of buccal caxity, psoriasis, haemorrhoids, varicose ulcers, bed sores, "diabetic feet", atopic eczema, acne, cold sores, sore spots, nail fungi, falling hair, dandruff or old-age itchiness.
- this solution can be newly used for suppressing mycotic infections and putrefactive processes on paws, cloven hoofs, hoofs, hair, skin, eyes, shells, in mouth, scales, mucous membranes and auditory passages of animals or in the body of animals.
- this new solution enables to use the mixture for the treatment of human diseases of fungal, bacterial or other origin on skin, mucous membranes, in the hair part or in the body of humans. Further to that, this solution enables to use the mixtures for animals against the diseases of fungal, bacterial or other origin on paws, cloven hoofs, hoofs, hair, skin, eyes, shells, in mouth, scales, mucous membranes and auditory passages of animals or in the body of animals.
- Another application is also the violation of bio-films on heterogeneous materials used both in human and veterinary medicine (artificial valves, joint replacements, contact lenses, catheters etc.).
- the technical solution also enables to eliminate microflora virtually from all objects, which come into contact with humans and animals, e.g. from interiors of the means of transport, seat furniture, animal cages etc.
- the above mentioned new applications of the fungal organism Pythium oligandrum are also enabled by the new application of other components forming the mixture. New mixtures were examined and selected because of better, more understandable and more comfortable application of the preparation for the consumer so that their possible preparation for application and the actual application were clear, simple and comfortable and corresponded to the common habits in the twenty first century.
- oligandrin Various inert carriers are used for the new mixtures in different ratios, which do not damage the microscopic fungus Pythium oligandrum (creation of the fungal fibres and characteristic echinate oospore, zoospore and zoosporangia) and producing various enzymes, which are collectively called oligandrin.
- Pythium oligandrum is used in various concentrations for these new mixtures, when the number of the reproductive organs of the fungal organism Pythium oligandrum is higher than 2x 10 5 in 1 g of the mixture.
- the new inert components are especially biological organic and/or inorganic solutions, such as oil bases, physiological solutions, aromatic solutions, ointments, suppositories, pastes, creams, toothpastes, mouthwashes etc. Further to that, it concerns suspensions, emulsions or solid (loose) compositions of individual components, e.g. dusting powders, powders etc. or suspensions, emulsions or solutions from such individual substances.
- weight expression as stated above, it means that the mixture includes 0.001 to 25 weight portions of Pythium oligandrum and 75 to 99.999 weight portions of inert components.
- Example No. 1 mixture for suppressing aphthae and parodontosis
- Colloid silicon dioxide (Aerosil 200) 4.8 %
- Vitamin E (Covi ox T 70) 0.08%
- Example No. 3 mixture for softening dry skin in case of diabetes Pythium oligandrum 1.72%
- Vitamin E (Covi ox T 70) 0.08% Balm oil 0.03%
- Example No. 4 mixture for suppressing symptoms of psoriasis
- the antifungal mixture with fungal organism Pythium oligandrum can be used both in human and veterinary medicine, in the cosmetic industry and also in households for maintaining cleanness and for elimination of fungi from walls of building objects and for violation of bio-films on heterogeneous materials and for elimination of microflora on objects coming in contact with humans or 5 animals.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Communicable Diseases (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012537295A JP6053521B2 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture using the fungal organism Psium-Oligandrum |
CN200980162343.5A CN102655754B (en) | 2009-11-04 | 2009-12-14 | Antimycotic mixture comprising fungal organism pythium oligandrum |
EA201270615A EA033217B1 (en) | 2009-11-04 | 2009-12-14 | Use of a composition comprising fungal organism pythium oligandrum |
BR112012010689A BR112012010689B8 (en) | 2009-11-04 | 2009-12-14 | antifungal mixture with fungal organism |
AU2009354904A AU2009354904B2 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism Pythium oligandrum |
MX2012005278A MX337150B (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum. |
US13/505,788 US20120225035A1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
UAA201206771A UA107204C2 (en) | 2009-11-04 | 2009-12-14 | ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism |
EP09809019.4A EP2496088B1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
CA2779541A CA2779541C (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
TNP2012000194A TN2012000194A1 (en) | 2009-11-04 | 2012-04-26 | Antifungal mixture with fungal organism pythium oligandrum |
IL219510A IL219510A (en) | 2009-11-04 | 2012-05-01 | Antifungal mixture with fungal organism pythium oligandrum |
ZA2012/03481A ZA201203481B (en) | 2009-11-04 | 2012-05-14 | Antifungal mixture with fungal organism pythium oligandrum |
MA34876A MA33756B1 (en) | 2009-11-04 | 2012-05-17 | Antifungal mixture with fungal organism Bitum oligdrum |
US14/735,347 US20150313953A1 (en) | 2009-11-04 | 2015-06-10 | Antifungal mixture witih fungal organism pythium oligandrum |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZPV2009-724 | 2009-11-04 | ||
CZ20090724A CZ2009724A3 (en) | 2009-11-04 | 2009-11-04 | Mildew-proof mixture containing Pythium oligandrum fungal organism |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/505,788 A-371-Of-International US20120225035A1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
US14/152,554 Continuation US9084750B2 (en) | 2009-11-04 | 2014-01-10 | Antifungal mixture with fungal organism Pythium oligandrum |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011054322A1 true WO2011054322A1 (en) | 2011-05-12 |
WO2011054322A8 WO2011054322A8 (en) | 2012-06-07 |
Family
ID=42289467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ2009/000154 WO2011054322A1 (en) | 2009-11-04 | 2009-12-14 | Antifungal mixture with fungal organism pythium oligandrum |
Country Status (16)
Country | Link |
---|---|
US (3) | US20120225035A1 (en) |
EP (1) | EP2496088B1 (en) |
JP (2) | JP6053521B2 (en) |
CN (1) | CN102655754B (en) |
AU (1) | AU2009354904B2 (en) |
BR (1) | BR112012010689B8 (en) |
CA (1) | CA2779541C (en) |
CZ (1) | CZ2009724A3 (en) |
EA (1) | EA033217B1 (en) |
IL (1) | IL219510A (en) |
MA (1) | MA33756B1 (en) |
MX (1) | MX337150B (en) |
TN (1) | TN2012000194A1 (en) |
UA (1) | UA107204C2 (en) |
WO (1) | WO2011054322A1 (en) |
ZA (1) | ZA201203481B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016112881A1 (en) * | 2015-01-16 | 2016-07-21 | Bio Agens Research And Development - Bard S.R.O. | Dual microbial preparation for long-term suppression or prevention of symptoms of opportunistic microbial infections |
WO2018001392A1 (en) * | 2016-07-01 | 2018-01-04 | Bio Agens Research And Development - Bard, S.R.O. | Preparation with the viable mycoparasitic microorganism pythium oligandrum for the treatment of dermaphytoses and yeast infections on the skin and mucous membranes, method of determining the cell's viability of the microorganism pythium oligandrum and method of applying the preparation |
WO2018068774A3 (en) * | 2016-10-14 | 2018-05-17 | Biopreparáty, Spol. S R.O | Biological antifugal liquid preparation with microorganism pythium oligandrum and method of production |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130034618A1 (en) * | 2011-08-04 | 2013-02-07 | Karen Swenholt | Compositions for treating the integument |
EP3324986B1 (en) * | 2015-07-20 | 2021-11-24 | Quorum Innovations, LLC | Materials and methods for improving immune responses and the skin and/or mucosal barrier function |
CN105519584A (en) * | 2016-01-12 | 2016-04-27 | 郑州曹氏天正生物技术有限公司 | Freeze-dried powdered, dried and suspended fungicide and preparation method thereof |
WO2017173240A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
WO2017173241A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
CZ307642B6 (en) * | 2016-07-08 | 2019-01-30 | Bio Agens Research And Development - Bard S.R.O. | A preparation containing the viable mycoparasitic microorganism Pythium oligandrum for the treatment of dermatophytoses and yeast infections on the skin and mucous membranes and a method of application of the preparation |
WO2018098152A1 (en) | 2016-11-23 | 2018-05-31 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
EA201990201A1 (en) * | 2017-10-16 | 2019-08-30 | Биопрепараты, Спол. С Р.О. | LIQUID BIOLOGICAL ANTI-FUNGAL DRUG CONTAINING THE PYTHIUM OLIGANDRUM MICRO-ORGANISM AND METHOD FOR PRODUCING IT |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259317A (en) | 1978-07-05 | 1981-03-31 | Vyzkummy Ustav Rostlinne Vyroby | Preparation for the protection of emerging sugar beets against damping-off, and method of its production |
CZ9883U1 (en) * | 1999-11-18 | 2000-04-14 | Dasa Doc Ing Drsc Vesely | A skin protection agent using the fungus Pythium oligandrum |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1532797A (en) * | 1996-01-16 | 1997-08-11 | Sybron Chemical Holdings, Inc. | Cleaner and sanitizer formulation |
US5961971A (en) * | 1996-10-17 | 1999-10-05 | University Of Florida | Biocontrol of fungal soilborne pathogens by Pythium oligandrum |
JP2002512007A (en) * | 1998-04-17 | 2002-04-23 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | Efficient and highly selective control of microorganisms |
CZ20013072A3 (en) * | 2001-08-24 | 2003-04-16 | Dáša Doc. Ing. Drsc. Veselý | Pythium oligandrum, resistance inducer to leaf diseases |
WO2009132343A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating onchomycosis |
CZ20377U1 (en) * | 2009-11-04 | 2009-12-18 | Bio Agens Research And Development - Bard, S.R.O. | Mildew-proof mixture containing Pythium oligandrum fungal organism |
-
2009
- 2009-11-04 CZ CZ20090724A patent/CZ2009724A3/en unknown
- 2009-12-14 MX MX2012005278A patent/MX337150B/en active IP Right Grant
- 2009-12-14 JP JP2012537295A patent/JP6053521B2/en active Active
- 2009-12-14 BR BR112012010689A patent/BR112012010689B8/en active IP Right Grant
- 2009-12-14 UA UAA201206771A patent/UA107204C2/en unknown
- 2009-12-14 AU AU2009354904A patent/AU2009354904B2/en active Active
- 2009-12-14 EP EP09809019.4A patent/EP2496088B1/en active Active
- 2009-12-14 EA EA201270615A patent/EA033217B1/en not_active IP Right Cessation
- 2009-12-14 CA CA2779541A patent/CA2779541C/en active Active
- 2009-12-14 WO PCT/CZ2009/000154 patent/WO2011054322A1/en active Application Filing
- 2009-12-14 CN CN200980162343.5A patent/CN102655754B/en active Active
- 2009-12-14 US US13/505,788 patent/US20120225035A1/en not_active Abandoned
-
2012
- 2012-04-26 TN TNP2012000194A patent/TN2012000194A1/en unknown
- 2012-05-01 IL IL219510A patent/IL219510A/en active IP Right Grant
- 2012-05-14 ZA ZA2012/03481A patent/ZA201203481B/en unknown
- 2012-05-17 MA MA34876A patent/MA33756B1/en unknown
-
2014
- 2014-01-10 US US14/152,554 patent/US9084750B2/en active Active
-
2015
- 2015-06-10 US US14/735,347 patent/US20150313953A1/en not_active Abandoned
-
2016
- 2016-08-29 JP JP2016166810A patent/JP2017019832A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259317A (en) | 1978-07-05 | 1981-03-31 | Vyzkummy Ustav Rostlinne Vyroby | Preparation for the protection of emerging sugar beets against damping-off, and method of its production |
CZ9883U1 (en) * | 1999-11-18 | 2000-04-14 | Dasa Doc Ing Drsc Vesely | A skin protection agent using the fungus Pythium oligandrum |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016112881A1 (en) * | 2015-01-16 | 2016-07-21 | Bio Agens Research And Development - Bard S.R.O. | Dual microbial preparation for long-term suppression or prevention of symptoms of opportunistic microbial infections |
US20180000877A1 (en) * | 2015-01-16 | 2018-01-04 | Bio Agens Research And Development - Bard S.R.O. | Dual microbial preparation for long-term suppression or prevention of symptoms of opportunistic microbial infections |
WO2018001392A1 (en) * | 2016-07-01 | 2018-01-04 | Bio Agens Research And Development - Bard, S.R.O. | Preparation with the viable mycoparasitic microorganism pythium oligandrum for the treatment of dermaphytoses and yeast infections on the skin and mucous membranes, method of determining the cell's viability of the microorganism pythium oligandrum and method of applying the preparation |
US11331356B2 (en) | 2016-07-01 | 2022-05-17 | Bio Agens Research And Development—Bard, S.R.O. | Preparation with the mycoparasitic microorganism pythium oligandrum for the treatment of dermaphytoses and yeast infections on the skin and mucouses, method of determing the cell's viability of the microorganism pythium oligandrum and method of applying the preparation |
WO2018068774A3 (en) * | 2016-10-14 | 2018-05-17 | Biopreparáty, Spol. S R.O | Biological antifugal liquid preparation with microorganism pythium oligandrum and method of production |
IL265999A (en) * | 2016-10-14 | 2019-06-30 | Biopreparaty Spol S R O | Biological antifugal liquid preparation with microorganism pythium oligandrum and method of production |
Also Published As
Publication number | Publication date |
---|---|
CN102655754B (en) | 2017-08-22 |
CA2779541C (en) | 2018-12-04 |
EP2496088A1 (en) | 2012-09-12 |
UA107204C2 (en) | 2014-12-10 |
JP2013510100A (en) | 2013-03-21 |
JP2017019832A (en) | 2017-01-26 |
EP2496088B1 (en) | 2018-12-05 |
EA033217B1 (en) | 2019-09-30 |
CN102655754A (en) | 2012-09-05 |
BR112012010689A2 (en) | 2015-09-15 |
US20140127167A1 (en) | 2014-05-08 |
WO2011054322A8 (en) | 2012-06-07 |
AU2009354904B2 (en) | 2014-12-04 |
BR112012010689B8 (en) | 2021-05-25 |
JP6053521B2 (en) | 2016-12-27 |
US20150313953A1 (en) | 2015-11-05 |
ZA201203481B (en) | 2012-12-27 |
CZ302297B6 (en) | 2011-02-09 |
US9084750B2 (en) | 2015-07-21 |
MX337150B (en) | 2016-02-15 |
AU2009354904A1 (en) | 2012-06-21 |
IL219510A (en) | 2017-01-31 |
MX2012005278A (en) | 2012-08-23 |
EA201270615A1 (en) | 2012-09-28 |
BR112012010689B1 (en) | 2020-12-22 |
CZ2009724A3 (en) | 2011-02-09 |
TN2012000194A1 (en) | 2013-12-12 |
IL219510A0 (en) | 2012-06-28 |
CA2779541A1 (en) | 2011-05-12 |
MA33756B1 (en) | 2012-11-01 |
US20120225035A1 (en) | 2012-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9084750B2 (en) | Antifungal mixture with fungal organism Pythium oligandrum | |
CN106029062A (en) | Compositions and method for destabilizing, altering, and dispersing biofilms | |
EA021050B1 (en) | Synergistic preservative blends | |
Osmanov et al. | The antiseptic Miramistin: a review of its comparative in vitro and clinical activity | |
JP2007510712A (en) | Bactericidal composition and methods for making and using the same | |
CN111135160A (en) | Foam wash-free antibacterial liquid for personal protection and preparation method thereof | |
US20190274948A1 (en) | Prebiotic cosmetic compositions and use of the prebiotic cosmetic compositions | |
AU2018214127A1 (en) | Volatile organic compound formulations having antimicrobial activity | |
AU2012100972A4 (en) | Antifungal mixture with fungal organism pythium oligandrum | |
CN101146526A (en) | Anti-microbial agent | |
KR20170123613A (en) | Opportunistic infectious microorganism Double microorganism preparation for long-term inhibition or prevention of symptoms of infection | |
CZ20377U1 (en) | Mildew-proof mixture containing Pythium oligandrum fungal organism | |
AU2006235798A1 (en) | Topical composition | |
JP7029749B2 (en) | Preventive / ameliorating agent for skin diseases caused by fungi | |
JP2018528154A (en) | Preparations for the treatment of dermatomycosis and yeast infections of the skin and mucous membranes, including the viable fungal parasitic microorganism Picium origandrum, methods for determining cell viability of the microorganism Picium origandrum and methods for applying the preparation | |
CN112516068A (en) | Application of bacillus subtilis in antibacterial, deodorizing and cleaning products | |
EP3856165A1 (en) | Volatile organic compound formulations having antimicrobial activity | |
US20220218637A1 (en) | Volatile Organic Compound Formulations Having Antimicrobial Activity | |
Phalalo et al. | An Enzymatic Based Formulation for Cleaning and Disinfection of Medical Devices | |
US7157499B2 (en) | Medical application of oxidized monoterpenes | |
Granholm | Effects of cobalt nanoparticles on Microsporum canis in vitro | |
Polova et al. | The substantiation of the optimal pH range of the preventive spray for veterinary | |
Prysiazhniuk et al. | A COMPARATIVE STUDY OF THE ANTIBACTERIAL ACTIVITY OF OINTMENT BASED ON DIPEROXYAZELAIC AND BENZALKONIUM CHLORIDE AND" PEROXYGEL 3%" PREPARATION | |
CS264623B1 (en) | Biocide agent | |
BG1271U1 (en) | Antimycotic preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980162343.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09809019 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2779541 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 219510 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13505788 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/005278 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012537295 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009809019 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1300/KOLNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009354904 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201206771 Country of ref document: UA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201270615 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 2009354904 Country of ref document: AU Date of ref document: 20091214 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012010689 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012010689 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120504 |